Because the model utilized was technically a generalized estimating equation (GEE) approach, the issue of over-overdispersion was automatically accounted for, since the variances were empirically estimated, rather than under the constraints of the Poisson distribution
It could be over in a few months
Key Points Semaglutide is not FDA-approved to treat PCOS Some studies, however, show that semaglutide helped women with PCOS lose weight Weight loss often helps PCOS symptoms by reducing insulin resistance and hormonal imbalances Proper nutrition plays a key role in managing PCOS PCOS carries serious long-term health consequences, including an increased risk of diabetes, heart disease, and fertility challenges
While no significant effects were observed for other arrhythmic or renal outcomes, the overall evidence supports semaglutide as a valuable therapeutic option for managing CV risk in patients with overweight or obesity
Never use research-grade or grey-market peptides as a substitute for an approved medication, and always consult a licensed healthcare provider before starting, stopping, or changing any treatment
Who this is for